State of Alaska Department of Revenue Sells 635 Shares of Masimo Co. (NASDAQ:MASI)

State of Alaska Department of Revenue lessened its holdings in shares of Masimo Co. (NASDAQ:MASIGet Rating) by 8.6% during the 3rd quarter, Holdings Channel.com reports. The fund owned 6,708 shares of the medical equipment provider’s stock after selling 635 shares during the period. State of Alaska Department of Revenue’s holdings in Masimo were worth $946,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Masimo by 1.5% during the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider’s stock valued at $695,050,000 after acquiring an additional 71,918 shares in the last quarter. FMR LLC raised its position in Masimo by 1.7% during the second quarter. FMR LLC now owns 2,104,939 shares of the medical equipment provider’s stock valued at $275,052,000 after acquiring an additional 35,438 shares in the last quarter. Nomura Holdings Inc. bought a new position in Masimo during the second quarter valued at approximately $242,537,000. State Street Corp raised its position in Masimo by 1.6% during the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider’s stock valued at $251,928,000 after acquiring an additional 27,261 shares in the last quarter. Finally, Liontrust Investment Partners LLP raised its position in Masimo by 19.0% during the second quarter. Liontrust Investment Partners LLP now owns 1,199,300 shares of the medical equipment provider’s stock valued at $156,713,000 after acquiring an additional 191,700 shares in the last quarter. Institutional investors own 87.67% of the company’s stock.

Masimo Trading Up 1.8 %

NASDAQ MASI opened at $154.35 on Monday. The company has a market cap of $8.11 billion, a PE ratio of 51.11 and a beta of 0.86. The company has a current ratio of 2.12, a quick ratio of 1.28 and a debt-to-equity ratio of 0.76. Masimo Co. has a 12 month low of $108.89 and a 12 month high of $262.28. The stock has a 50 day moving average of $139.59 and a 200-day moving average of $141.96.

Masimo (NASDAQ:MASIGet Rating) last released its quarterly earnings data on Tuesday, November 8th. The medical equipment provider reported $1.00 EPS for the quarter, beating the consensus estimate of $0.92 by $0.08. Masimo had a return on equity of 18.04% and a net margin of 9.78%. The company had revenue of $549.30 million during the quarter, compared to the consensus estimate of $533.96 million. On average, equities research analysts anticipate that Masimo Co. will post 4.45 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on MASI. StockNews.com began coverage on shares of Masimo in a research report on Wednesday, October 12th. They issued a “hold” rating on the stock. Wolfe Research raised shares of Masimo from a “peer perform” rating to an “outperform” rating and set a $165.00 price target on the stock in a research report on Thursday, September 15th. Piper Sandler dropped their price target on shares of Masimo from $150.00 to $135.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 9th. Loop Capital initiated coverage on shares of Masimo in a research note on Tuesday, September 13th. They issued a “buy” rating and a $206.00 price objective on the stock. Finally, Jefferies Financial Group initiated coverage on shares of Masimo in a research note on Wednesday, October 12th. They issued a “buy” rating and a $180.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $188.25.

Insider Transactions at Masimo

In related news, CEO Joe E. Kiani purchased 7,040 shares of the firm’s stock in a transaction that occurred on Thursday, December 15th. The shares were bought at an average price of $144.79 per share, for a total transaction of $1,019,321.60. Following the completion of the transaction, the chief executive officer now owns 46,818 shares of the company’s stock, valued at $6,778,778.22. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Joe E. Kiani purchased 7,040 shares of Masimo stock in a transaction dated Thursday, December 15th. The shares were bought at an average cost of $144.79 per share, for a total transaction of $1,019,321.60. Following the completion of the acquisition, the chief executive officer now owns 46,818 shares in the company, valued at approximately $6,778,778.22. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Joe E. Kiani purchased 31,994 shares of Masimo stock in a transaction dated Monday, November 14th. The shares were purchased at an average price of $123.99 per share, for a total transaction of $3,966,936.06. Following the completion of the acquisition, the chief executive officer now owns 39,778 shares of the company’s stock, valued at approximately $4,932,074.22. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 46,818 shares of company stock valued at $5,992,495. 9.70% of the stock is currently owned by corporate insiders.

Masimo Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Read More

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIGet Rating).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.